Recent advances in fecal gene detection for colorectal cancer diagnosis

被引:1
|
作者
He, Siyu [1 ]
Zhou, Chenglin [1 ]
Peng, Hailin [1 ]
Lin, Mei [1 ]
机构
[1] Dalian Med Univ, Taizhou Peoples Hosp, Clin Lab, Taizhou 225300, Jiangsu, Peoples R China
关键词
colorectal cancer; diagnosis; feces; gene detection; NONINVASIVE BIOMARKER; STOOL; DNA; IDENTIFICATION; MUTATIONS; CARCINOMA; MICRORNA-20A; PROGNOSIS; SAMPLES; MIR-21;
D O I
10.2217/bmm-2021-0269
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There has been a gradual increase in the incidence of colorectal cancer (CRC) in recent years. Most patients lack obvious early symptoms, but are commonly in mid and advanced stages when the symptoms become evident, with rather high mortalities. Early diagnosis, treatment and recurrence monitoring are crucial to improving the recovery rate of CRC. Studies have shown that tumor-related genes can be detected in the feces of CRC patients. Owing to non-invasiveness, convenient sampling and continuous dynamic monitoring, fecal gene detection may be applicable to CRC screening, diagnosis, prognostic assessment and recurrence monitoring. Herein, we review the research advances in fecal gene detection for CRC diagnosis.
引用
收藏
页码:1299 / 1308
页数:10
相关论文
共 50 条
  • [21] Fecal microRNAs as non-invasive biomarkers for the detection of colorectal cancer: a systematic review
    Francavilla, Antonio
    Tarallo, Sonia
    Pardini, Barbara
    Naccarati, Alessio
    MINERVA BIOTECNOLOGICA, 2019, 31 (01) : 30 - 42
  • [22] Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer
    Luo, Xiaoya
    Wu, Yongdong
    Ji, Ming
    Zhang, Shutian
    CLINICAL LABORATORY, 2019, 65 (05) : 733 - 741
  • [23] Screening of Pathogenic Genes for Colorectal Cancer and Deep Learning in the Diagnosis of Colorectal Cancer
    Li, Yanke
    Zhang, Fuqiang
    Xing, Chengzhong
    IEEE ACCESS, 2020, 8 : 114916 - 114929
  • [24] Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer
    Zhang, Yue
    Wang, Yin
    Zhang, Bingqiang
    Li, Peifeng
    Zhao, Yi
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [25] Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
    Lee, Yujin
    Ni, Jie
    Beretov, Julia
    Wasinger, Valerie C. C.
    Graham, Peter
    Li, Yong
    MOLECULAR CANCER, 2023, 22 (01)
  • [26] Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage
    Li, Linfang
    Xing, Shan
    Wu, Miantao
    Ao, Yufeng
    Zheng, Xin
    Cai, Rongzeng
    Han, Runkun
    Li, Jingcong
    Li, Xiaohui
    Zeng, Qiuyao
    CANCER CONTROL, 2021, 28
  • [27] Recent advances in the pharmacological treatment of colorectal cancer
    Messersmith, W
    Laheru, D
    Hidalgo, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) : 423 - 434
  • [28] Recent advances in miniaturized systems for colorectal cancer diagnosis: Cells, biomarkers, and therapeutic medications
    Ibrahim, Rania S.
    Abd El-Wadood, Hanaa M.
    El-Zahry, Marwa R.
    Hosny, Noha M.
    MICROCHEMICAL JOURNAL, 2025, 211
  • [29] Evaluation of fecal SYPL1 as a diagnostic biomarker in colorectal cancer
    Shu, Tao
    Wu, Kaiwen
    Guo, Yuanbiao
    He, Qiao
    Song, Xiaoyu
    Shan, Jing
    Wu, Liping
    Liu, Jia
    Wang, Zhiming
    Liu, Lei
    Sun, Xiaobin
    CLINICAL BIOCHEMISTRY, 2022, 103 : 8 - 15
  • [30] Metabolite profiling of fecal water extracts from human colorectal cancer
    Monleon, Daniel
    Manuel Morales, Jose
    Barrasa, Antonio
    Antonio Lopez, Jose
    Vazquez, Carlos
    Celda, Bernardo
    NMR IN BIOMEDICINE, 2009, 22 (03) : 342 - 348